Evidenced Based Management: A Journey for Physicians
-
Historical Perspective, Epidemiology, and Methodology
-
Overview of the SCD guidelines and chapters
-
Process and methodology
-
Consensus Statements
-
Clinical Practice Guidelines and the institute of Medicine
-
Prevention of invasive infection
-
Screening for Renal Disease
-
Electrocardiogram Screening
-
Screening for hypertension
-
Screening for Retinopathy
-
Screening for risk of stroke using neuroimaging
-
Screening for Pulmonary disease
-
Reproductive counseling
-
Contraception
-
Clinical Preventive services
-
Immunizations
-
Vaso-Occlusive Crisis
-
Fever
-
Acute Renal Failure
-
Priapism
-
Hepatobiliary Complications
-
Acute Anemia
-
Splenic Sequestration
-
Acute Chest Syndrome
-
Acute Stroke
-
Multisystem Organ Failure
-
Acute Ocular Conditions
-
Chronic pain
-
Avascular Necrosis
-
Leg Ulcers
-
Pulmonary Hypertension
-
Renal Complications
-
Stuttering/Recurrent Priapism
-
Ophthalmologic Complications
-
Summary of the Evidence
-
Hydroxurea Treatment Recommendations
-
Consensus Treatment Protocol and Technical remarks for the implementation of Hydroxyurea Therapy
-
Indications for transfusions
-
Recommendations for Acute and Chronic Transfusion Therapy
-
Appropriate Management/ Monitoring
-
Consensus Protocol for Monitoring Individuals on Chronic Transfusion Therapy
-
Complications of Transfusions
-
Recommendations for the Management and Prevention of Transfusion Complications
-
New Research is Needed
-
Data Systems That Meet the Highest Standards of Scientific Rigor Can Be Invaluable
-
Improved Phenotyping is needed
-
Broad collaborations for Research and Care
-
Beyond Efficacy
-
Look, Listen, Empathize and Ask
Data Systems That Meet the Highest Standards of Scientific Rigor Can Be Invaluable
SCFA_Coach September 25, 2023
Well-designed databases with linked biorepositories are required to complete observational studies and enable investigators to generate and test specific hypotheses. The databases must include longitudinal information on patient outcomes, therapies, health care services received, and the health system context in which the services were provided. The patient cohorts must be well-characterized by genotypic and phenotypic data. For example, this might be facilitated by mobilizing the Nation’s diverse newborn hemoglobinopathy screening programs to pool and analyze their data. Some of these State-supported and academic center-based programs already have assembled valuable information on treatment and long-term outcomes of individuals identified as having SCD, which could be leveraged for the longitudinal studies
Responses